300 related articles for article (PubMed ID: 34440633)
1. TRIM22. A Multitasking Antiviral Factor.
Pagani I; Poli G; Vicenzi E
Cells; 2021 Jul; 10(8):. PubMed ID: 34440633
[TBL] [Abstract][Full Text] [Related]
2. The interferon-stimulated gene TRIM22: A double-edged sword in HIV-1 infection.
Vicenzi E; Poli G
Cytokine Growth Factor Rev; 2018 Apr; 40():40-47. PubMed ID: 29650252
[TBL] [Abstract][Full Text] [Related]
3. TRIM22 inhibits influenza A virus infection by targeting the viral nucleoprotein for degradation.
Di Pietro A; Kajaste-Rudnitski A; Oteiza A; Nicora L; Towers GJ; Mechti N; Vicenzi E
J Virol; 2013 Apr; 87(8):4523-33. PubMed ID: 23408607
[TBL] [Abstract][Full Text] [Related]
4. Mutations Conferring Increased Sensitivity to Tripartite Motif 22 Restriction Accumulated Progressively in the Nucleoprotein of Seasonal Influenza A (H1N1) Viruses between 1918 and 2009.
Pagani I; Di Pietro A; Oteiza A; Ghitti M; Mechti N; Naffakh N; Vicenzi E
mSphere; 2018 Apr; 3(2):. PubMed ID: 29624498
[TBL] [Abstract][Full Text] [Related]
5. TRIM5α and TRIM22 are differentially regulated according to HIV-1 infection phase and compartment.
Singh R; Patel V; Mureithi MW; Naranbhai V; Ramsuran D; Tulsi S; Hiramen K; Werner L; Mlisana K; Altfeld M; Luban J; Kasprowicz V; Dheda K; Abdool Karim SS; Ndung'u T
J Virol; 2014 Apr; 88(8):4291-303. PubMed ID: 24478420
[TBL] [Abstract][Full Text] [Related]
6. Association of TRIM22 with the type 1 interferon response and viral control during primary HIV-1 infection.
Singh R; Gaiha G; Werner L; McKim K; Mlisana K; Luban J; Walker BD; Karim SS; Brass AL; Ndung'u T;
J Virol; 2011 Jan; 85(1):208-16. PubMed ID: 20980524
[TBL] [Abstract][Full Text] [Related]
7. Constitutive TRIM22 Expression in the Respiratory Tract Confers a Pre-Existing Defence Against Influenza A Virus Infection.
Charman M; McFarlane S; Wojtus JK; Sloan E; Dewar R; Leeming G; Al-Saadi M; Hunter L; Carroll MW; Stewart JP; Digard P; Hutchinson E; Boutell C
Front Cell Infect Microbiol; 2021; 11():689707. PubMed ID: 34621686
[TBL] [Abstract][Full Text] [Related]
8. TRIM22 inhibits HIV-1 transcription independently of its E3 ubiquitin ligase activity, Tat, and NF-kappaB-responsive long terminal repeat elements.
Kajaste-Rudnitski A; Marelli SS; Pultrone C; Pertel T; Uchil PD; Mechti N; Mothes W; Poli G; Luban J; Vicenzi E
J Virol; 2011 May; 85(10):5183-96. PubMed ID: 21345949
[TBL] [Abstract][Full Text] [Related]
9. Tripartite Motif 22 (TRIM22) protein restricts herpes simplex virus 1 by epigenetic silencing of viral immediate-early genes.
Reddi TS; Merkl PE; Lim SY; Letvin NL; Knipe DM
PLoS Pathog; 2021 Feb; 17(2):e1009281. PubMed ID: 33524065
[TBL] [Abstract][Full Text] [Related]
10. The C-Terminal Tail of TRIM56 Dictates Antiviral Restriction of Influenza A and B Viruses by Impeding Viral RNA Synthesis.
Liu B; Li NL; Shen Y; Bao X; Fabrizio T; Elbahesh H; Webby RJ; Li K
J Virol; 2016 May; 90(9):4369-4382. PubMed ID: 26889027
[TBL] [Abstract][Full Text] [Related]
11. The E3 ligase TRIM22 restricts SARS-CoV-2 replication by promoting proteasomal degradation of NSP8.
Fan L; Zhou Y; Wei X; Feng W; Guo H; Li Y; Gao X; Zhou J; Wen Y; Wu Y; Shen X; Liu L; Xu G; Zhang Z
mBio; 2024 Feb; 15(2):e0232023. PubMed ID: 38275298
[TBL] [Abstract][Full Text] [Related]
12. HIV-1 transcriptional silencing caused by TRIM22 inhibition of Sp1 binding to the viral promoter.
Turrini F; Marelli S; Kajaste-Rudnitski A; Lusic M; Van Lint C; Das AT; Harwig A; Berkhout B; Vicenzi E
Retrovirology; 2015 Dec; 12():104. PubMed ID: 26683615
[TBL] [Abstract][Full Text] [Related]
13. Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1.
Ramos I; Smith G; Ruf-Zamojski F; Martínez-Romero C; Fribourg M; Carbajal EA; Hartmann BM; Nair VD; Marjanovic N; Monteagudo PL; DeJesus VA; Mutetwa T; Zamojski M; Tan GS; Jayaprakash C; Zaslavsky E; Albrecht RA; Sealfon SC; García-Sastre A; Fernandez-Sesma A
J Virol; 2019 Oct; 93(20):. PubMed ID: 31375585
[TBL] [Abstract][Full Text] [Related]
14. Expression of TRIM22 mRNA in chronic hepatitis C patients treated with direct-acting antiviral drugs.
Naveed M; Ali A; Sheikh N; Rafique S; Idrees M
APMIS; 2020 Apr; 128(4):326-334. PubMed ID: 31863490
[TBL] [Abstract][Full Text] [Related]
15. The interferon response inhibits HIV particle production by induction of TRIM22.
Barr SD; Smiley JR; Bushman FD
PLoS Pathog; 2008 Feb; 4(2):e1000007. PubMed ID: 18389079
[TBL] [Abstract][Full Text] [Related]
16. TRIM22 E3 ubiquitin ligase activity is required to mediate antiviral activity against encephalomyocarditis virus.
Eldin P; Papon L; Oteiza A; Brocchi E; Lawson TG; Mechti N
J Gen Virol; 2009 Mar; 90(Pt 3):536-545. PubMed ID: 19218198
[TBL] [Abstract][Full Text] [Related]
17. Tripartite motif-containing 22 inhibits the activity of hepatitis B virus core promoter, which is dependent on nuclear-located RING domain.
Gao B; Duan Z; Xu W; Xiong S
Hepatology; 2009 Aug; 50(2):424-33. PubMed ID: 19585648
[TBL] [Abstract][Full Text] [Related]
18. Modulation of Innate Immune Responses by the Influenza A NS1 and PA-X Proteins.
Nogales A; Martinez-Sobrido L; Topham DJ; DeDiego ML
Viruses; 2018 Dec; 10(12):. PubMed ID: 30545063
[TBL] [Abstract][Full Text] [Related]
19. Interferons command Trim22 to fight against viruses.
Lian Q; Sun B
Cell Mol Immunol; 2017 Sep; 14(9):794-796. PubMed ID: 28782753
[No Abstract] [Full Text] [Related]
20. Identification of lncRNA-155 encoded by MIR155HG as a novel regulator of innate immunity against influenza A virus infection.
Maarouf M; Chen B; Chen Y; Wang X; Rai KR; Zhao Z; Liu S; Li Y; Xiao M; Chen JL
Cell Microbiol; 2019 Aug; 21(8):e13036. PubMed ID: 31045320
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
